Mindfulness therapy tested to calm Parkinson's stress

NCT ID NCT05779137

Ongoing Symptom relief Sponsor: Radboud University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether mindfulness-based cognitive therapy (MBCT) can reduce psychological distress in people with Parkinson's disease. 174 participants with mild-to-moderate stress symptoms will either receive MBCT or continue usual care. The main goal is to see if MBCT lowers anxiety and depression scores after the program.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mindfulness-based cognitive therapy
What this could lead to: If it works, this could offer a drug-free way to ease anxiety and depression in Parkinson's, and possibly slow disease progression.
What could go wrong: This is a mid-sized trial testing a behavioral intervention, not a drug. Results may be modest or not generalizable, and benefits may not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Disease Progression Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON'S DISEASE

Contacts and locations

Locations

Donders Centre for Cognitive Neuroimaging

Nijmegen, 6525 EN, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.